Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nanog homeobox pseudogenes are multiple non-coding derivatives of the functional Nanog homeobox gene (NANOG) spread across the human genome, designated as NANOGP1, NANOGP2, etc. [4]. They are not functional genes and do not encode proteins. NANOG itself is a master transcription factor required for the maintenance of embryonic stem cell pluripotency, but its pseudogenes have lost coding capacity through evolutionary processes. Although a few reports describe the transcription of some NANOG pseudogenes, and rare instances of mRNA detection in certain cancers, these pseudogenes do not function as receptors, enzymes, or therapeutic targets and have no confirmed physiological function or drug interactions [1][2][4]. The confusion sometimes arises because some pseudogenes are transcribed in specific cancers, but only the functional NANOG protein is considered an actionable therapeutic target in regenerative medicine and oncology [4]. Key points: - ENSG00000255356 represents a NANOG pseudogene, not the functional NANOG gene. - No drugs target this pseudogene; it is not an enzyme, receptor, transporter, or similar class. - Pseudogenes are sometimes reported as cancer biomarkers, but this is not an established or routine clinical use. - If you are referring to the canonical, protein-coding Nanog homeobox gene (NANOG), that is a different entity with distinct roles in stem cell biology and cancer; pseudogenes should not be listed as therapeutic targets [1][2][4].
none
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nanog homeobox pseudogene (none).